BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, April 3, 2026
Home » Authors » Kim Coghill

Articles by Kim Coghill

Millennium To Drop Asthma Drug, Citing Safety Issues

July 16, 2002
By Kim Coghill

Millennium To Drop Asthma Drug, Citing Safety Issues

July 16, 2002
By Kim Coghill

NIH Has Awarded One Grant For Embryonic Stem Cell Research

July 15, 2002
By Kim Coghill
WASHINGTON - It's been almost a year since President Bush gave the National Institutes of Health the authority to award research grants to scientists interested in studying an existing 64 - now 72 - human embryonic stem cell lines located in 10 laboratories across the world. (BioWorld Today)
Read More

NIH Has Awarded One Grant For Embryonic Stem Cell Research

July 15, 2002
By Kim Coghill
WASHINGTON - It's been almost a year since President Bush gave the National Institutes of Health the authority to award research grants to scientists interested in studying an existing 64 - now 72 - human embryonic stem cell lines located in 10 laboratories across the world. (BioWorld Today)
Read More

Bioethics Council Votes 10-7 For Therapeutic Cloning Moratorium

July 12, 2002
By Kim Coghill

Bioethics Council Votes 10-7 For Therapeutic Cloning Moratorium

July 12, 2002
By Kim Coghill

Synaptic Licenses Preclinical Receptor Compounds To P&G

July 11, 2002
By Kim Coghill

Synaptic Licenses Preclinical Receptor Compounds To P&G

July 11, 2002
By Kim Coghill

Santarus Partners Technology With TAP In Potential $100M Deal

July 10, 2002
By Kim Coghill
Santarus Inc. stands to gain up to $100 million through a licensing agreement announced Tuesday with TAP Pharmaceutical Products Inc. aimed at developing a next-generation therapy for upper gastrointestinal diseases. (BioWorld Today)
Read More

Santarus Partners Technology With TAP In Potential $100M Deal

July 10, 2002
By Kim Coghill
Santarus Inc. stands to gain up to $100 million through a licensing agreement announced Tuesday with TAP Pharmaceutical Products Inc. aimed at developing a next-generation therapy for upper gastrointestinal diseases. (BioWorld Today)
Read More
Previous 1 2 … 112 113 114 115 116 117 118 119 120 … 142 143 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 2, 2026.
  • Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

    Small-molecule TREM2 agonist advances to treat Alzheimer’s

    BioWorld Science
    Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
  • Amyloid beta peptides on neurons

    Amlogenyx’s AM-805 reduces amyloid plaques in AD

    BioWorld Science
    The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 31, 2026
  • Atai Therapeutics patents new 5-HT2 receptor agonists

    BioWorld Science
    Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing